Trial Profile
Impact of Hyperbilirubinemia Among HIV Patients Treated With Atazanavir
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Aug 2015
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 28 Aug 2015 New trial record